Pipeline

Monotherapy Novel NDV strain RY-1 expressing transgenes

Discovery

preclinical phase

phase 1

phase 2

phase 3

Monotherapy Novel NDV strain RY-2 expressing transgenes

Discovery

preclinical phase

phase 1

phase 2

phase 3

Monotherapy Novel NDV strain RY-3 expressing transgenes

Discovery

preclinical phase

phase 1

phase 2

phase 3

Combined with Immunotherapy

Discovery

preclinical phase

phase 1

phase 2

phase 3